GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Interest Received

InhaleRx (ASX:IRX) Interest Received : A$0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Interest Received?

InhaleRx's Interest Received for the six months ended in Jun. 2023 was A$0.00 Mil.

InhaleRx's Interest Received for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00 Mil.


InhaleRx Interest Received Historical Data

The historical data trend for InhaleRx's Interest Received can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Interest Received Chart

InhaleRx Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Received
Get a 7-Day Free Trial 0.03 - - 0.02 -

InhaleRx Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Received Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

InhaleRx Interest Received Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Interest Received represents interest received by the company in the direct cash flow method.

Interest Received for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InhaleRx Interest Received Related Terms

Thank you for viewing the detailed overview of InhaleRx's Interest Received provided by GuruFocus.com. Please click on the following links to see related term pages.


InhaleRx (ASX:IRX) Business Description

Traded in Other Exchanges
N/A
Address
126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000
InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx (ASX:IRX) Headlines

No Headlines